Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfurous Acid SCHEMBL6057036 | 1.00 | CA1 (0.43) | CA1CA2CHRM2CHRM4CHRM5 | |
| SCHEMBL28190503 | 0.90 | CHRM2 (0.32) | CA1CA2CHRM2CHRM4CHRM5 | |
| SCHEMBL284131 | 0.85 | TSHR (0.32) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Sulfurous Acid SCHEMBL7689669 | 0.84 | CHRM2 (0.30) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL27822896 | 0.82 | — | — | |
| Metasulfurous Acid SCHEMBL21332618 | 0.80 | NPSR1 (0.35) | — | |
| Methyl Alcohol SCHEMBL341831 | 0.76 | — | — | |
| Hydrogen Peroxide SCHEMBL139129 | 0.76 | — | — | |
| Sulfurous Acid SCHEMBL10483923 | 0.76 | — | — | |
| Hydrogen Peroxide SCHEMBL139127 | 0.76 | ALDH1A1 (0.36) | CA1CA2CHRM2CHRM4CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3709810-A1 | PROCESS AND INTERMIDIATES FOR THE PREPARATION OF CERTAIN MESOIONIC PESTICIDES | E. I. du Pont de Nemours and Company (US) | 2020-09-23 | — | — | EP | claimed |
| CN-111683530-A | Processes and intermediates for preparing certain mesoionic insecticides | 纳幕尔杜邦公司 | 2020-09-18 | — | — | CN | claimed |
| WO-2019173173-A1 | PROCESS AND INTERMIDIATES FOR THE PREPARATION OF CERTAIN MESOIONIC PESTICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2019-09-12 | — | — | WO | claimed |
| CN-103553977-A | Benzyl sulfonic acid derivative preparation method | LI KAI | 2014-02-05 | — | — | CN | claimed |
| US-4400396-A | Antithrombotic treatment with organic amine sulfites and bisulfites | T & R CHEMICALS, INC. (US) | 1983-08-23 | — | — | US | claimed |
| US-12534442-B2 | Benzisoxazole derivative | Sumitomo Pharma Co., Ltd. (JP) | 2026-01-27 | — | — | US | disclosed |
| US-12356988-B2 | Process and intermediates for the preparation of certain mesoionic pesticides | CORTEVA AGRISCIENCE LLC (US) | 2025-07-15 | — | — | US | disclosed |
| US-20230202991-A1 | BENZISOXAZOLE DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2023-06-29 | — | — | US | disclosed |
| EP-4180090-A1 | BENZISOXAZOLE DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2023-05-17 | — | — | EP | disclosed |
| CN-115836058-A | Benzisoxazole derivatives | 住友制药株式会社 | 2023-03-21 | — | — | CN | disclosed |
| US-11535599-B2 | Benzisoxazole derivative | Sumitomo Pharma Co., Ltd. (JP) | 2022-12-27 | — | — | US | disclosed |
| US-20220289694-A1 | BENZISOXAZOLE DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2022-09-15 | — | — | US | disclosed |
| US-5344949-A | Quaternary ammonium sulfonates from organoammonium hydrogen sulfite and epoxy compounds or organosilicon epoxy compounds | TH. GOLDSCHMIDT AG (DE) | 1994-09-06 | — | — | US | disclosed |
| EP-0581082-A1 | Process for the preparation of surface-active anion-cation complexes | Th. Goldschmidt AG (DE) | 1994-02-02 | — | — | EP | disclosed |
| EP-0043274-B1 | ANTITHROMBOTIC TREATMENT | T AND R CHEMICALS, INC. (US) | 1985-01-16 | — | — | EP | disclosed |
| US-4404202-A | AMINE SULFITE AND BISULFITE SALTS | T & R CHEMICALS, INC. (US) | 1983-09-13 | — | — | US | disclosed |
| US-4401654-A | Anticoagulant methods with sulfur dioxide | T & R CHEMICALS, INC. (US) | 1983-08-30 | — | — | US | disclosed |
| US-4400396-A | Antithrombotic treatment with organic amine sulfites and bisulfites | T & R CHEMICALS, INC. (US) | 1983-08-23 | — | — | US | disclosed |
| WO-1982000097-A1 | THE USE OF CERTAIN SULFITES OR BISULFITES IN COMPOSITIONS FOR TREATING THROMBOTIC CONDITIONS | T & R CHEM INC (US) | 1982-01-21 | — | — | WO | disclosed |
| EP-0043274-A2 | Antithrombotic treatment | T AND R CHEMICALS, INC. (US) | 1982-01-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11535599-B2 | Benzisoxazole derivative | HDAC3, GABRA5, HDAC2 | CA1 1839/4885CA2 1610/4885CHRM2 264/4885 |
| US-20230202991-A1 | BENZISOXAZOLE DERIVATIVE | HDAC3, GABRA5, HDAC2 | CA1 1839/4885CA2 1610/4885CHRM2 264/4885 |
| US-12356988-B2 | Process and intermediates for the preparation of certain mesoionic pesticides | SCO2, CHRM5, C3AR1 | CA1 92/4885CA2 144/4885CHRM2 7/4885 |
| US-20220289694-A1 | BENZISOXAZOLE DERIVATIVE | HDAC3, GABRA5, HDAC2 | CA1 1839/4885CA2 1610/4885CHRM2 264/4885 |
| US-12534442-B2 | Benzisoxazole derivative | GABRA6, SLC6A1, GABRA1 | CA1 818/4885CA2 601/4885CHRM2 260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.